BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38643349)

  • 1. Tear Protein Markers for Diabetic Retinopathy and Diabetic Macular Edema - Towards an Early Diagnosis and Better Prognosis.
    Sharma S; Belenje A; Takkar B; Narula R; Rathi VM; Tyagi M; Rani PK; Narayanan R; Kaur I
    Semin Ophthalmol; 2024 Apr; ():1-11. PubMed ID: 38643349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Biomarkers Related to Th17 Cells in Macular Edema of Diabetic Retinopathy: Cutting-Edge Comprehensive Bioinformatics Analysis and
    Huang J; Zhou Q
    Front Immunol; 2022; 13():858972. PubMed ID: 35651615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
    JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms.
    Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J
    J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between peripheral blood inflammatory markers and diabetic macular edema in patients with severe diabetic retinopathy.
    Zhu Y; Cai Q; Li P; Zhou Y; Xu M; Song Y
    Ann Palliat Med; 2022 Mar; 11(3):984-992. PubMed ID: 35365028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for Diagnosis of Diabetic Retinopathy and Diabetic Macula Edema- A Review.
    Suriyasekeran K; Santhanamahalingam S; Duraisamy M
    Adv Exp Med Biol; 2021; 1307():357-373. PubMed ID: 32166636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy.
    Graham PS; Kaidonis G; Abhary S; Gillies MC; Daniell M; Essex RW; Chang JH; Lake SR; Pal B; Jenkins AJ; Hewitt AW; Lamoureux EL; Hykin PG; Petrovsky N; Brown MA; Craig JE; Burdon KP
    BMC Med Genet; 2018 May; 19(1):71. PubMed ID: 29739359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+T Cell-Related Gene Biomarkers in Macular Edema of Diabetic Retinopathy.
    Huang J; Zhou Q
    Front Endocrinol (Lausanne); 2022; 13():907396. PubMed ID: 35937822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving Treatment of Diabetic Retinopathy.
    Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
    Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choriocapillaris Flow Deficit as a Biomarker for Diabetic Retinopathy and Diabetic Macular Edema: 3-Year Longitudinal Cohort.
    Chen Y; Zhu Z; Cheng W; Bulloch G; Chen Y; Liao H; Li Y; Liang X; Huang W; He M; Wang W;
    Am J Ophthalmol; 2023 Apr; 248():76-86. PubMed ID: 36436548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.
    Zhang J; Zhang J; Zhang C; Zhang J; Gu L; Luo D; Qiu Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.
    Rechtman E; Harris A; Garzozi HJ; Ciulla TA
    Clin Ophthalmol; 2007 Dec; 1(4):383-91. PubMed ID: 19668515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate for diabetic retinopathy.
    Kataoka SY; Lois N; Kawano S; Kataoka Y; Inoue K; Watanabe N
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013318. PubMed ID: 37310870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema.
    Bhutia CU; Kaur P; Singh K; Kaur S
    Indian J Ophthalmol; 2023 Jun; 71(6):2521-2525. PubMed ID: 37322673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.
    Lois N; Cook J; Wang A; Aldington S; Mistry H; Maredza M; McAuley D; Aslam T; Bailey C; Chong V; Ghanchi F; Scanlon P; Sivaprasad S; Steel D; Styles C; Azuara-Blanco A; Prior L; Waugh N
    Health Technol Assess; 2021 May; 25(32):1-104. PubMed ID: 34060440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: A review.
    Sanjiv N; Osathanugrah P; Harrell M; Siegel NH; Ness S; Chen X; Cabral H; Subramanian ML
    J Natl Med Assoc; 2022 Apr; 114(2):123-140. PubMed ID: 35078668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
    Ciulla TA; Amador AG; Zinman B
    Diabetes Care; 2003 Sep; 26(9):2653-64. PubMed ID: 12941734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.